Neptune Technologies & Bioressources Inc  

(Public, TSE:NTB)   Watch this stock  
Find more results for NTB
1.75
Aug 31 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 1.26 - 2.66
Open     -
Vol / Avg. 0.00/33,456.00
Mkt cap 134.93M
P/E     -
Div/yield     -
EPS -0.37
Shares 75.38M
Beta 1.62
Inst. own     -
Oct 13, 2015
Q2 2016 Neptune Technologies & Bioressources Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 14, 2015
Neptune Technologies & Bioressources Inc Annual Shareholders Meeting
Jul 14, 2015
Q1 2016 Neptune Technologies & Bioressources Inc Earnings Call - Webcast
Jul 13, 2015
Q1 2016 Neptune Technologies & Bioressources Inc Earnings Release
  

Key stats and ratios

Q2 (May '15) 2015
Net profit margin -183.61% -197.89%
Operating margin -228.69% -262.76%
EBITD margin - -251.35%
Return on average assets -20.71% -29.63%
Return on average equity -33.26% -52.86%
Employees 123 -
CDP Score - -

Address

545 Prom du Centropolis Suite 100
LAVAL, QC H7T 0A3
Canada
+1-450-6872262 (Phone)
+1-450-6872272 (Fax)

Website links

Description

Neptune Technologies & Bioressources Inc. (Neptune) is a Canada-based biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and NeuroBioPharmInc. The Neptune segment produces and commercializes nutraceutical products. The Company’s Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. The Company’s NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. The Company’s products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO) which come in capsule form and serve as a dietary supplement to consumers.

Officers and directors

Pierre Fitzgibbon Chairman of the Board
Age: 60
James Stuart Hamilton President, Chief Executive Officer, Director
Michel Timperio Senior Vice President of Sales - Global Sales
Pierre Lemieux Ph.D. Chief Operating Officer of Acasti
Jean-Daniel Belanger Corporate Secretary and Director - Corporate Affairs
Harlan W. Waksal M.D. Director
Age: 61
Valier Boivin Independent Director
Ronald Denis Independent Director
Adrian Montgomery Independent Director
John Moretz Independent Director